nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCG2—Leflunomide—systemic scleroderma	0.0613	0.0841	CbGbCtD
Verapamil—ABCC10—Methotrexate—systemic scleroderma	0.0588	0.0807	CbGbCtD
Verapamil—CYP2C8—Mometasone—systemic scleroderma	0.0507	0.0695	CbGbCtD
Verapamil—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0477	0.0654	CbGbCtD
Verapamil—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0419	0.0575	CbGbCtD
Verapamil—SLCO1A2—Prednisone—systemic scleroderma	0.0404	0.0554	CbGbCtD
Verapamil—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0379	0.052	CbGbCtD
Verapamil—ABCC3—Methotrexate—systemic scleroderma	0.037	0.0507	CbGbCtD
Verapamil—ABCC4—Methotrexate—systemic scleroderma	0.0282	0.0388	CbGbCtD
Verapamil—CYP1A2—Pentoxifylline—systemic scleroderma	0.0265	0.0364	CbGbCtD
Verapamil—CYP1A2—Leflunomide—systemic scleroderma	0.0253	0.0347	CbGbCtD
Verapamil—ABCB1—Lisinopril—systemic scleroderma	0.0232	0.0318	CbGbCtD
Verapamil—CYP2C9—Leflunomide—systemic scleroderma	0.0228	0.0313	CbGbCtD
Verapamil—ABCC1—Methotrexate—systemic scleroderma	0.0227	0.0311	CbGbCtD
Verapamil—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.021	0.0288	CbGbCtD
Verapamil—SLCO1A2—Methotrexate—systemic scleroderma	0.0203	0.0278	CbGbCtD
Verapamil—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0202	0.0277	CbGbCtD
Verapamil—SLCO1B1—Methotrexate—systemic scleroderma	0.0191	0.0262	CbGbCtD
Verapamil—ABCB1—Captopril—systemic scleroderma	0.0173	0.0238	CbGbCtD
Verapamil—ABCC2—Methotrexate—systemic scleroderma	0.0168	0.0231	CbGbCtD
Verapamil—CYP2D6—Captopril—systemic scleroderma	0.0163	0.0224	CbGbCtD
Verapamil—ABCG2—Methotrexate—systemic scleroderma	0.0152	0.0208	CbGbCtD
Verapamil—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0137	0.0187	CbGbCtD
Verapamil—CYP2C19—Prednisone—systemic scleroderma	0.0135	0.0186	CbGbCtD
Verapamil—ABCB1—Prednisone—systemic scleroderma	0.0109	0.015	CbGbCtD
Verapamil—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00818	0.0112	CbGbCtD
Verapamil—CYP2C9—cardial valve—systemic scleroderma	0.00806	0.158	CbGeAlD
Verapamil—CYP3A4—Prednisone—systemic scleroderma	0.00654	0.00898	CbGbCtD
Verapamil—ABCB1—Methotrexate—systemic scleroderma	0.00548	0.00752	CbGbCtD
Verapamil—CACNA1B—connective tissue—systemic scleroderma	0.00224	0.0438	CbGeAlD
Verapamil—CACNB4—tendon—systemic scleroderma	0.00165	0.0323	CbGeAlD
Verapamil—CACNB4—lung—systemic scleroderma	0.00145	0.0283	CbGeAlD
Verapamil—CACNA1G—digestive system—systemic scleroderma	0.00144	0.0283	CbGeAlD
Verapamil—CACNA1S—tendon—systemic scleroderma	0.00141	0.0276	CbGeAlD
Verapamil—CACNA1B—lung—systemic scleroderma	0.00135	0.0264	CbGeAlD
Verapamil—CACNB3—digestive system—systemic scleroderma	0.00133	0.026	CbGeAlD
Verapamil—CACNB1—tendon—systemic scleroderma	0.00132	0.0258	CbGeAlD
Verapamil—CACNB3—tendon—systemic scleroderma	0.00126	0.0247	CbGeAlD
Verapamil—CACNA1H—smooth muscle tissue—systemic scleroderma	0.0012	0.0234	CbGeAlD
Verapamil—CACNB3—lung—systemic scleroderma	0.00111	0.0217	CbGeAlD
Verapamil—CYP2C18—digestive system—systemic scleroderma	0.00106	0.0207	CbGeAlD
Verapamil—ABCB11—digestive system—systemic scleroderma	0.00103	0.0201	CbGeAlD
Verapamil—CACNA1C—connective tissue—systemic scleroderma	0.000997	0.0195	CbGeAlD
Verapamil—CACNA1C—smooth muscle tissue—systemic scleroderma	0.000912	0.0178	CbGeAlD
Verapamil—CACNB2—digestive system—systemic scleroderma	0.000892	0.0175	CbGeAlD
Verapamil—CACNB2—tendon—systemic scleroderma	0.000849	0.0166	CbGeAlD
Verapamil—KCNJ11—tendon—systemic scleroderma	0.000806	0.0158	CbGeAlD
Verapamil—CACNB2—lung—systemic scleroderma	0.000745	0.0146	CbGeAlD
Verapamil—CACNA1C—digestive system—systemic scleroderma	0.00072	0.0141	CbGeAlD
Verapamil—SCN5A—digestive system—systemic scleroderma	0.000698	0.0136	CbGeAlD
Verapamil—SLCO1B1—digestive system—systemic scleroderma	0.00069	0.0135	CbGeAlD
Verapamil—ABCC3—digestive system—systemic scleroderma	0.000655	0.0128	CbGeAlD
Verapamil—ABCC10—digestive system—systemic scleroderma	0.000652	0.0128	CbGeAlD
Verapamil—CACNA1D—lung—systemic scleroderma	0.000652	0.0127	CbGeAlD
Verapamil—ABCC10—tendon—systemic scleroderma	0.00062	0.0121	CbGeAlD
Verapamil—SLC22A4—digestive system—systemic scleroderma	0.000613	0.012	CbGeAlD
Verapamil—CACNA1C—lung—systemic scleroderma	0.000601	0.0118	CbGeAlD
Verapamil—SLC22A4—tendon—systemic scleroderma	0.000583	0.0114	CbGeAlD
Verapamil—SLCO1A2—digestive system—systemic scleroderma	0.000562	0.011	CbGeAlD
Verapamil—ABCC3—lung—systemic scleroderma	0.000547	0.0107	CbGeAlD
Verapamil—ABCC10—lung—systemic scleroderma	0.000544	0.0106	CbGeAlD
Verapamil—SLC6A4—digestive system—systemic scleroderma	0.000543	0.0106	CbGeAlD
Verapamil—ABCC4—digestive system—systemic scleroderma	0.000541	0.0106	CbGeAlD
Verapamil—ABCC2—digestive system—systemic scleroderma	0.000523	0.0102	CbGeAlD
Verapamil—ABCC4—tendon—systemic scleroderma	0.000515	0.0101	CbGeAlD
Verapamil—SLC22A4—lung—systemic scleroderma	0.000512	0.01	CbGeAlD
Verapamil—ABCB1—blood vessel—systemic scleroderma	0.000508	0.00994	CbGeAlD
Verapamil—SLC22A5—skin of body—systemic scleroderma	0.000507	0.00992	CbGeAlD
Verapamil—ABCC2—tendon—systemic scleroderma	0.000498	0.00974	CbGeAlD
Verapamil—SLCO1A2—lung—systemic scleroderma	0.000469	0.00918	CbGeAlD
Verapamil—SLC6A4—lung—systemic scleroderma	0.000453	0.00887	CbGeAlD
Verapamil—ABCC4—lung—systemic scleroderma	0.000452	0.00883	CbGeAlD
Verapamil—CYP2C19—digestive system—systemic scleroderma	0.00045	0.0088	CbGeAlD
Verapamil—CYP2B6—skin of body—systemic scleroderma	0.00044	0.00861	CbGeAlD
Verapamil—ABCC1—tendon—systemic scleroderma	0.000439	0.00858	CbGeAlD
Verapamil—SLC22A5—digestive system—systemic scleroderma	0.000406	0.00793	CbGeAlD
Verapamil—SLC22A5—tendon—systemic scleroderma	0.000386	0.00755	CbGeAlD
Verapamil—ABCC1—lung—systemic scleroderma	0.000385	0.00753	CbGeAlD
Verapamil—CYP1A2—digestive system—systemic scleroderma	0.000367	0.00719	CbGeAlD
Verapamil—CYP3A5—digestive system—systemic scleroderma	0.000354	0.00693	CbGeAlD
Verapamil—CYP2B6—digestive system—systemic scleroderma	0.000352	0.00689	CbGeAlD
Verapamil—CYP2C9—digestive system—systemic scleroderma	0.000349	0.00682	CbGeAlD
Verapamil—SLC22A5—lung—systemic scleroderma	0.000339	0.00662	CbGeAlD
Verapamil—ABCG2—lung—systemic scleroderma	0.000319	0.00624	CbGeAlD
Verapamil—CYP1A2—lung—systemic scleroderma	0.000307	0.006	CbGeAlD
Verapamil—Discomfort—Mycophenolic acid—systemic scleroderma	0.000296	0.00134	CcSEcCtD
Verapamil—CYP3A5—lung—systemic scleroderma	0.000296	0.00579	CbGeAlD
Verapamil—Pruritus—Mometasone—systemic scleroderma	0.000295	0.00134	CcSEcCtD
Verapamil—Tachycardia—Leflunomide—systemic scleroderma	0.000294	0.00134	CcSEcCtD
Verapamil—CYP2B6—lung—systemic scleroderma	0.000294	0.00575	CbGeAlD
Verapamil—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000293	0.00133	CcSEcCtD
Verapamil—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000291	0.00132	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000291	0.00132	CcSEcCtD
Verapamil—Angioedema—Lisinopril—systemic scleroderma	0.00029	0.00132	CcSEcCtD
Verapamil—Confusional state—Mycophenolic acid—systemic scleroderma	0.00029	0.00132	CcSEcCtD
Verapamil—Oedema—Mycophenolic acid—systemic scleroderma	0.000287	0.0013	CcSEcCtD
Verapamil—Nausea—Pentoxifylline—systemic scleroderma	0.000287	0.0013	CcSEcCtD
Verapamil—Infection—Mycophenolic acid—systemic scleroderma	0.000286	0.0013	CcSEcCtD
Verapamil—Vertigo—Lisinopril—systemic scleroderma	0.000285	0.00129	CcSEcCtD
Verapamil—Diarrhoea—Mometasone—systemic scleroderma	0.000285	0.00129	CcSEcCtD
Verapamil—Syncope—Lisinopril—systemic scleroderma	0.000285	0.00129	CcSEcCtD
Verapamil—Shock—Mycophenolic acid—systemic scleroderma	0.000283	0.00128	CcSEcCtD
Verapamil—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00128	CcSEcCtD
Verapamil—Hypotension—Leflunomide—systemic scleroderma	0.000282	0.00128	CcSEcCtD
Verapamil—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000281	0.00127	CcSEcCtD
Verapamil—Palpitations—Lisinopril—systemic scleroderma	0.00028	0.00127	CcSEcCtD
Verapamil—Loss of consciousness—Lisinopril—systemic scleroderma	0.000279	0.00127	CcSEcCtD
Verapamil—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000278	0.00126	CcSEcCtD
Verapamil—Muscular weakness—Prednisone—systemic scleroderma	0.000276	0.00125	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000275	0.00125	CcSEcCtD
Verapamil—Insomnia—Leflunomide—systemic scleroderma	0.000273	0.00124	CcSEcCtD
Verapamil—Paraesthesia—Leflunomide—systemic scleroderma	0.000271	0.00123	CcSEcCtD
Verapamil—Arthralgia—Lisinopril—systemic scleroderma	0.00027	0.00123	CcSEcCtD
Verapamil—Myalgia—Lisinopril—systemic scleroderma	0.00027	0.00123	CcSEcCtD
Verapamil—Chest pain—Lisinopril—systemic scleroderma	0.00027	0.00123	CcSEcCtD
Verapamil—Dyspnoea—Leflunomide—systemic scleroderma	0.000269	0.00122	CcSEcCtD
Verapamil—Hypotension—Mycophenolic acid—systemic scleroderma	0.000269	0.00122	CcSEcCtD
Verapamil—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000267	0.00121	CcSEcCtD
Verapamil—Discomfort—Lisinopril—systemic scleroderma	0.000267	0.00121	CcSEcCtD
Verapamil—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000267	0.00121	CcSEcCtD
Verapamil—Lethargy—Methotrexate—systemic scleroderma	0.000267	0.00121	CcSEcCtD
Verapamil—CYP3A4—digestive system—systemic scleroderma	0.000266	0.0052	CbGeAlD
Verapamil—Dyspepsia—Leflunomide—systemic scleroderma	0.000265	0.0012	CcSEcCtD
Verapamil—Vomiting—Mometasone—systemic scleroderma	0.000265	0.0012	CcSEcCtD
Verapamil—Dry mouth—Lisinopril—systemic scleroderma	0.000264	0.0012	CcSEcCtD
Verapamil—Sweating increased—Prednisone—systemic scleroderma	0.000263	0.0012	CcSEcCtD
Verapamil—Feeling abnormal—Azathioprine—systemic scleroderma	0.000263	0.00119	CcSEcCtD
Verapamil—Rash—Mometasone—systemic scleroderma	0.000262	0.00119	CcSEcCtD
Verapamil—Asthenia—Captopril—systemic scleroderma	0.000262	0.00119	CcSEcCtD
Verapamil—Dermatitis—Mometasone—systemic scleroderma	0.000262	0.00119	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000262	0.00119	CcSEcCtD
Verapamil—CYP2D6—digestive system—systemic scleroderma	0.000262	0.00512	CbGeAlD
Verapamil—Confusional state—Lisinopril—systemic scleroderma	0.000261	0.00119	CcSEcCtD
Verapamil—Headache—Mometasone—systemic scleroderma	0.000261	0.00118	CcSEcCtD
Verapamil—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00118	CcSEcCtD
Verapamil—Insomnia—Mycophenolic acid—systemic scleroderma	0.00026	0.00118	CcSEcCtD
Verapamil—Fatigue—Leflunomide—systemic scleroderma	0.00026	0.00118	CcSEcCtD
Verapamil—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000259	0.00118	CcSEcCtD
Verapamil—Oedema—Lisinopril—systemic scleroderma	0.000259	0.00118	CcSEcCtD
Verapamil—Pruritus—Captopril—systemic scleroderma	0.000259	0.00117	CcSEcCtD
Verapamil—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000258	0.00117	CcSEcCtD
Verapamil—Constipation—Leflunomide—systemic scleroderma	0.000258	0.00117	CcSEcCtD
Verapamil—Pain—Leflunomide—systemic scleroderma	0.000258	0.00117	CcSEcCtD
Verapamil—Infection—Lisinopril—systemic scleroderma	0.000257	0.00117	CcSEcCtD
Verapamil—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000256	0.00116	CcSEcCtD
Verapamil—Somnolence—Mycophenolic acid—systemic scleroderma	0.000256	0.00116	CcSEcCtD
Verapamil—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000255	0.00116	CcSEcCtD
Verapamil—Shock—Lisinopril—systemic scleroderma	0.000255	0.00116	CcSEcCtD
Verapamil—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000254	0.00115	CcSEcCtD
Verapamil—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000253	0.00115	CcSEcCtD
Verapamil—Tachycardia—Lisinopril—systemic scleroderma	0.000253	0.00115	CcSEcCtD
Verapamil—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00025	0.00114	CcSEcCtD
Verapamil—Diarrhoea—Captopril—systemic scleroderma	0.00025	0.00114	CcSEcCtD
Verapamil—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00025	0.00113	CcSEcCtD
Verapamil—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000249	0.00113	CcSEcCtD
Verapamil—Erectile dysfunction—Prednisone—systemic scleroderma	0.000249	0.00113	CcSEcCtD
Verapamil—Feeling abnormal—Leflunomide—systemic scleroderma	0.000248	0.00113	CcSEcCtD
Verapamil—Fatigue—Mycophenolic acid—systemic scleroderma	0.000248	0.00113	CcSEcCtD
Verapamil—Nausea—Mometasone—systemic scleroderma	0.000247	0.00112	CcSEcCtD
Verapamil—Pain—Mycophenolic acid—systemic scleroderma	0.000246	0.00112	CcSEcCtD
Verapamil—Constipation—Mycophenolic acid—systemic scleroderma	0.000246	0.00112	CcSEcCtD
Verapamil—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000246	0.00112	CcSEcCtD
Verapamil—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000244	0.00111	CcSEcCtD
Verapamil—Hypotension—Lisinopril—systemic scleroderma	0.000242	0.0011	CcSEcCtD
Verapamil—Dizziness—Captopril—systemic scleroderma	0.000242	0.0011	CcSEcCtD
Verapamil—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00109	CcSEcCtD
Verapamil—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00024	0.00109	CcSEcCtD
Verapamil—Urticaria—Leflunomide—systemic scleroderma	0.000239	0.00109	CcSEcCtD
Verapamil—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000238	0.00108	CcSEcCtD
Verapamil—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000237	0.00108	CcSEcCtD
Verapamil—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000237	0.00107	CcSEcCtD
Verapamil—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000237	0.00107	CcSEcCtD
Verapamil—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000237	0.00107	CcSEcCtD
Verapamil—Myocardial infarction—Prednisone—systemic scleroderma	0.000236	0.00107	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000236	0.00107	CcSEcCtD
Verapamil—Hypersensitivity—Azathioprine—systemic scleroderma	0.000235	0.00107	CcSEcCtD
Verapamil—Insomnia—Lisinopril—systemic scleroderma	0.000234	0.00106	CcSEcCtD
Verapamil—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000234	0.00106	CcSEcCtD
Verapamil—Paraesthesia—Lisinopril—systemic scleroderma	0.000233	0.00106	CcSEcCtD
Verapamil—Vomiting—Captopril—systemic scleroderma	0.000232	0.00106	CcSEcCtD
Verapamil—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000231	0.00105	CcSEcCtD
Verapamil—Dyspnoea—Lisinopril—systemic scleroderma	0.000231	0.00105	CcSEcCtD
Verapamil—Rash—Captopril—systemic scleroderma	0.000231	0.00105	CcSEcCtD
Verapamil—Dermatitis—Captopril—systemic scleroderma	0.00023	0.00105	CcSEcCtD
Verapamil—Somnolence—Lisinopril—systemic scleroderma	0.00023	0.00104	CcSEcCtD
Verapamil—Headache—Captopril—systemic scleroderma	0.000229	0.00104	CcSEcCtD
Verapamil—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00104	CcSEcCtD
Verapamil—Dyspepsia—Lisinopril—systemic scleroderma	0.000228	0.00103	CcSEcCtD
Verapamil—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000227	0.00103	CcSEcCtD
Verapamil—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000227	0.00103	CcSEcCtD
Verapamil—Infection—Mycophenolate mofetil—systemic scleroderma	0.000225	0.00102	CcSEcCtD
Verapamil—Fatigue—Lisinopril—systemic scleroderma	0.000223	0.00101	CcSEcCtD
Verapamil—Shock—Mycophenolate mofetil—systemic scleroderma	0.000223	0.00101	CcSEcCtD
Verapamil—Hypersensitivity—Leflunomide—systemic scleroderma	0.000222	0.00101	CcSEcCtD
Verapamil—Constipation—Lisinopril—systemic scleroderma	0.000221	0.00101	CcSEcCtD
Verapamil—Pain—Lisinopril—systemic scleroderma	0.000221	0.00101	CcSEcCtD
Verapamil—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000221	0.00101	CcSEcCtD
Verapamil—Bradycardia—Prednisone—systemic scleroderma	0.00022	0.001	CcSEcCtD
Verapamil—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000996	CcSEcCtD
Verapamil—Diarrhoea—Azathioprine—systemic scleroderma	0.000218	0.000991	CcSEcCtD
Verapamil—Nausea—Captopril—systemic scleroderma	0.000217	0.000986	CcSEcCtD
Verapamil—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000217	0.000983	CcSEcCtD
Verapamil—Asthenia—Leflunomide—systemic scleroderma	0.000216	0.000981	CcSEcCtD
Verapamil—Feeling abnormal—Lisinopril—systemic scleroderma	0.000213	0.000969	CcSEcCtD
Verapamil—Pruritus—Leflunomide—systemic scleroderma	0.000213	0.000968	CcSEcCtD
Verapamil—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000962	CcSEcCtD
Verapamil—Dizziness—Azathioprine—systemic scleroderma	0.000211	0.000958	CcSEcCtD
Verapamil—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00021	0.000953	CcSEcCtD
Verapamil—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000208	0.000945	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000207	0.000938	CcSEcCtD
Verapamil—Asthenia—Mycophenolic acid—systemic scleroderma	0.000206	0.000936	CcSEcCtD
Verapamil—Diarrhoea—Leflunomide—systemic scleroderma	0.000206	0.000936	CcSEcCtD
Verapamil—Urticaria—Lisinopril—systemic scleroderma	0.000206	0.000934	CcSEcCtD
Verapamil—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000931	CcSEcCtD
Verapamil—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000925	CcSEcCtD
Verapamil—Pruritus—Mycophenolic acid—systemic scleroderma	0.000203	0.000923	CcSEcCtD
Verapamil—Vomiting—Azathioprine—systemic scleroderma	0.000203	0.000921	CcSEcCtD
Verapamil—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000918	CcSEcCtD
Verapamil—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000916	CcSEcCtD
Verapamil—Drowsiness—Methotrexate—systemic scleroderma	0.000202	0.000915	CcSEcCtD
Verapamil—Rash—Azathioprine—systemic scleroderma	0.000201	0.000913	CcSEcCtD
Verapamil—Dermatitis—Azathioprine—systemic scleroderma	0.000201	0.000912	CcSEcCtD
Verapamil—Flushing—Prednisone—systemic scleroderma	0.000201	0.000912	CcSEcCtD
Verapamil—Headache—Azathioprine—systemic scleroderma	0.0002	0.000907	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.0002	0.000907	CcSEcCtD
Verapamil—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000907	CcSEcCtD
Verapamil—Dizziness—Leflunomide—systemic scleroderma	0.000199	0.000905	CcSEcCtD
Verapamil—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000197	0.000893	CcSEcCtD
Verapamil—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000881	CcSEcCtD
Verapamil—Pain—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000881	CcSEcCtD
Verapamil—Sweating—Methotrexate—systemic scleroderma	0.000193	0.000877	CcSEcCtD
Verapamil—Vomiting—Leflunomide—systemic scleroderma	0.000192	0.00087	CcSEcCtD
Verapamil—Alopecia—Prednisone—systemic scleroderma	0.000191	0.000868	CcSEcCtD
Verapamil—Hypersensitivity—Lisinopril—systemic scleroderma	0.000191	0.000866	CcSEcCtD
Verapamil—Dizziness—Mycophenolic acid—systemic scleroderma	0.00019	0.000863	CcSEcCtD
Verapamil—Rash—Leflunomide—systemic scleroderma	0.00019	0.000862	CcSEcCtD
Verapamil—Dermatitis—Leflunomide—systemic scleroderma	0.00019	0.000862	CcSEcCtD
Verapamil—Nausea—Azathioprine—systemic scleroderma	0.00019	0.00086	CcSEcCtD
Verapamil—Headache—Leflunomide—systemic scleroderma	0.000189	0.000857	CcSEcCtD
Verapamil—ABCB1—digestive system—systemic scleroderma	0.000188	0.00368	CbGeAlD
Verapamil—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000849	CcSEcCtD
Verapamil—Asthenia—Lisinopril—systemic scleroderma	0.000186	0.000843	CcSEcCtD
Verapamil—Pruritus—Lisinopril—systemic scleroderma	0.000183	0.000832	CcSEcCtD
Verapamil—Vomiting—Mycophenolic acid—systemic scleroderma	0.000183	0.00083	CcSEcCtD
Verapamil—Rash—Mycophenolic acid—systemic scleroderma	0.000181	0.000823	CcSEcCtD
Verapamil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000181	0.000822	CcSEcCtD
Verapamil—Hepatitis—Methotrexate—systemic scleroderma	0.000181	0.000821	CcSEcCtD
Verapamil—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000818	CcSEcCtD
Verapamil—Headache—Mycophenolic acid—systemic scleroderma	0.00018	0.000817	CcSEcCtD
Verapamil—Pharyngitis—Methotrexate—systemic scleroderma	0.00018	0.000815	CcSEcCtD
Verapamil—Nausea—Leflunomide—systemic scleroderma	0.000179	0.000812	CcSEcCtD
Verapamil—Vision blurred—Prednisone—systemic scleroderma	0.000178	0.000806	CcSEcCtD
Verapamil—Diarrhoea—Lisinopril—systemic scleroderma	0.000177	0.000804	CcSEcCtD
Verapamil—Visual impairment—Methotrexate—systemic scleroderma	0.000174	0.000791	CcSEcCtD
Verapamil—Agitation—Prednisone—systemic scleroderma	0.000173	0.000786	CcSEcCtD
Verapamil—Angioedema—Prednisone—systemic scleroderma	0.000172	0.000782	CcSEcCtD
Verapamil—Dizziness—Lisinopril—systemic scleroderma	0.000171	0.000777	CcSEcCtD
Verapamil—Erythema multiforme—Methotrexate—systemic scleroderma	0.000171	0.000776	CcSEcCtD
Verapamil—Nausea—Mycophenolic acid—systemic scleroderma	0.000171	0.000775	CcSEcCtD
Verapamil—Vertigo—Prednisone—systemic scleroderma	0.000169	0.000768	CcSEcCtD
Verapamil—Syncope—Prednisone—systemic scleroderma	0.000169	0.000767	CcSEcCtD
Verapamil—Tinnitus—Methotrexate—systemic scleroderma	0.000169	0.000766	CcSEcCtD
Verapamil—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000759	CcSEcCtD
Verapamil—Loss of consciousness—Prednisone—systemic scleroderma	0.000166	0.000752	CcSEcCtD
Verapamil—Vomiting—Lisinopril—systemic scleroderma	0.000165	0.000747	CcSEcCtD
Verapamil—Rash—Lisinopril—systemic scleroderma	0.000163	0.000741	CcSEcCtD
Verapamil—Convulsion—Prednisone—systemic scleroderma	0.000163	0.000741	CcSEcCtD
Verapamil—Dermatitis—Lisinopril—systemic scleroderma	0.000163	0.00074	CcSEcCtD
Verapamil—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000739	CcSEcCtD
Verapamil—Hypertension—Prednisone—systemic scleroderma	0.000163	0.000738	CcSEcCtD
Verapamil—Headache—Lisinopril—systemic scleroderma	0.000162	0.000736	CcSEcCtD
Verapamil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000729	CcSEcCtD
Verapamil—Arthralgia—Prednisone—systemic scleroderma	0.00016	0.000728	CcSEcCtD
Verapamil—Myalgia—Prednisone—systemic scleroderma	0.00016	0.000728	CcSEcCtD
Verapamil—Alopecia—Methotrexate—systemic scleroderma	0.00016	0.000726	CcSEcCtD
Verapamil—Discomfort—Prednisone—systemic scleroderma	0.000158	0.000719	CcSEcCtD
Verapamil—ABCB1—lung—systemic scleroderma	0.000157	0.00307	CbGeAlD
Verapamil—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000705	CcSEcCtD
Verapamil—Nausea—Lisinopril—systemic scleroderma	0.000154	0.000698	CcSEcCtD
Verapamil—Anaphylactic shock—Prednisone—systemic scleroderma	0.000154	0.000698	CcSEcCtD
Verapamil—Oedema—Prednisone—systemic scleroderma	0.000154	0.000698	CcSEcCtD
Verapamil—Infection—Prednisone—systemic scleroderma	0.000153	0.000694	CcSEcCtD
Verapamil—Shock—Prednisone—systemic scleroderma	0.000151	0.000687	CcSEcCtD
Verapamil—Tachycardia—Prednisone—systemic scleroderma	0.00015	0.000681	CcSEcCtD
Verapamil—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000681	CcSEcCtD
Verapamil—Hyperhidrosis—Prednisone—systemic scleroderma	0.000149	0.000675	CcSEcCtD
Verapamil—Vision blurred—Methotrexate—systemic scleroderma	0.000148	0.000674	CcSEcCtD
Verapamil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000655	CcSEcCtD
Verapamil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000649	CcSEcCtD
Verapamil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000649	CcSEcCtD
Verapamil—Headache—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000645	CcSEcCtD
Verapamil—Vertigo—Methotrexate—systemic scleroderma	0.000141	0.000642	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00014	0.000636	CcSEcCtD
Verapamil—Insomnia—Prednisone—systemic scleroderma	0.000139	0.000631	CcSEcCtD
Verapamil—Paraesthesia—Prednisone—systemic scleroderma	0.000138	0.000627	CcSEcCtD
Verapamil—Convulsion—Methotrexate—systemic scleroderma	0.000136	0.000619	CcSEcCtD
Verapamil—Dyspepsia—Prednisone—systemic scleroderma	0.000135	0.000614	CcSEcCtD
Verapamil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000612	CcSEcCtD
Verapamil—Myalgia—Methotrexate—systemic scleroderma	0.000134	0.000609	CcSEcCtD
Verapamil—Arthralgia—Methotrexate—systemic scleroderma	0.000134	0.000609	CcSEcCtD
Verapamil—Chest pain—Methotrexate—systemic scleroderma	0.000134	0.000609	CcSEcCtD
Verapamil—Fatigue—Prednisone—systemic scleroderma	0.000133	0.000602	CcSEcCtD
Verapamil—Discomfort—Methotrexate—systemic scleroderma	0.000132	0.000601	CcSEcCtD
Verapamil—Constipation—Prednisone—systemic scleroderma	0.000132	0.000597	CcSEcCtD
Verapamil—Confusional state—Methotrexate—systemic scleroderma	0.00013	0.000588	CcSEcCtD
Verapamil—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000129	0.000583	CcSEcCtD
Verapamil—Infection—Methotrexate—systemic scleroderma	0.000128	0.00058	CcSEcCtD
Verapamil—Feeling abnormal—Prednisone—systemic scleroderma	0.000127	0.000575	CcSEcCtD
Verapamil—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000124	0.000564	CcSEcCtD
Verapamil—Urticaria—Prednisone—systemic scleroderma	0.000122	0.000555	CcSEcCtD
Verapamil—Hypotension—Methotrexate—systemic scleroderma	0.00012	0.000545	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000117	0.000532	CcSEcCtD
Verapamil—Insomnia—Methotrexate—systemic scleroderma	0.000116	0.000528	CcSEcCtD
Verapamil—Paraesthesia—Methotrexate—systemic scleroderma	0.000115	0.000524	CcSEcCtD
Verapamil—Dyspnoea—Methotrexate—systemic scleroderma	0.000115	0.00052	CcSEcCtD
Verapamil—Somnolence—Methotrexate—systemic scleroderma	0.000114	0.000519	CcSEcCtD
Verapamil—Hypersensitivity—Prednisone—systemic scleroderma	0.000113	0.000514	CcSEcCtD
Verapamil—Dyspepsia—Methotrexate—systemic scleroderma	0.000113	0.000514	CcSEcCtD
Verapamil—Fatigue—Methotrexate—systemic scleroderma	0.000111	0.000503	CcSEcCtD
Verapamil—Asthenia—Prednisone—systemic scleroderma	0.00011	0.000501	CcSEcCtD
Verapamil—Pain—Methotrexate—systemic scleroderma	0.00011	0.000499	CcSEcCtD
Verapamil—Pruritus—Prednisone—systemic scleroderma	0.000109	0.000494	CcSEcCtD
Verapamil—Feeling abnormal—Methotrexate—systemic scleroderma	0.000106	0.000481	CcSEcCtD
Verapamil—Diarrhoea—Prednisone—systemic scleroderma	0.000105	0.000478	CcSEcCtD
Verapamil—Urticaria—Methotrexate—systemic scleroderma	0.000102	0.000463	CcSEcCtD
Verapamil—Dizziness—Prednisone—systemic scleroderma	0.000102	0.000462	CcSEcCtD
Verapamil—Vomiting—Prednisone—systemic scleroderma	9.78e-05	0.000444	CcSEcCtD
Verapamil—Rash—Prednisone—systemic scleroderma	9.7e-05	0.00044	CcSEcCtD
Verapamil—Dermatitis—Prednisone—systemic scleroderma	9.69e-05	0.00044	CcSEcCtD
Verapamil—Headache—Prednisone—systemic scleroderma	9.63e-05	0.000437	CcSEcCtD
Verapamil—Hypersensitivity—Methotrexate—systemic scleroderma	9.47e-05	0.00043	CcSEcCtD
Verapamil—Asthenia—Methotrexate—systemic scleroderma	9.22e-05	0.000419	CcSEcCtD
Verapamil—Nausea—Prednisone—systemic scleroderma	9.13e-05	0.000415	CcSEcCtD
Verapamil—Pruritus—Methotrexate—systemic scleroderma	9.09e-05	0.000413	CcSEcCtD
Verapamil—Diarrhoea—Methotrexate—systemic scleroderma	8.79e-05	0.000399	CcSEcCtD
Verapamil—Dizziness—Methotrexate—systemic scleroderma	8.5e-05	0.000386	CcSEcCtD
Verapamil—Vomiting—Methotrexate—systemic scleroderma	8.17e-05	0.000371	CcSEcCtD
Verapamil—Rash—Methotrexate—systemic scleroderma	8.1e-05	0.000368	CcSEcCtD
Verapamil—Dermatitis—Methotrexate—systemic scleroderma	8.1e-05	0.000367	CcSEcCtD
Verapamil—Headache—Methotrexate—systemic scleroderma	8.05e-05	0.000365	CcSEcCtD
Verapamil—Nausea—Methotrexate—systemic scleroderma	7.63e-05	0.000347	CcSEcCtD
